Go back to feed

Citrini on AI, Robotics & Healthcare

Good, wide-ranging episode from Citrini who has been pretty on-point so far with his calls on AI names and cycle timing.

Link: Monetary Matters - The 5th Inning: Citrini on Phase II of AI, Semis, Robotics, Healthcare, and Teradyne

Overview: thinks we are in inning 5-6 in this AI cycle, and outperformance is much more difficult than buying Nvidia in 2023.

US:

  • Bullish Teradyne for cyclical lows (and exposure to AMZN robotics)
  • Bullish automotive cycle given robotics tailwinds underpriced
  • Bullish Lilly for pipeline
  • Bullish Applovin for ads exposure
  • Bearish US healthcare insurers

CHINA:

  • Bullish WeChat for data moats (heavy agree)
  • Bearish China macro overall from RE / Consumption Overhang
  • Mixed review on Chinese robotics - quite capable / cheap, but aggressive price competition
  • Bullish property servicing companies (bummed out valuations)

And plenty more...

Featured Mini-post

[
]

11 early stage Robotics Companies

Our research

Citrini on AI, Robotics & Healthcare

Our research

Understanding MCP from a Monad Perspective

Our research

Chinese AI, Capitalism, and an American DeepSeek

Our research

Chain of Thought Monitorability

Our research

Welcome to the Intelligence Feed

Announcement
See all mini-posts